Methods and agents for modulating an immune response
OwnerChristian Munzinventor
Life of this patent
Estimating the term…
Abstract
This invention is directed to the targeting of proteins or peptides of interest to an autophagosome, for their presentation on a major histocompatibility complex (MHC) class II molecule and methods of use thereof. Nucleic acids, vectors comprising the same, and compositions for targeting proteins or peptides of interest to an autophagosome, for their presentation on a major histocompatibility complex (MHC) class II molecule are disclosed as are methods of use thereof for stimulating or enhancing immune responses in a subject.
Claims71
A nucleic acid encoding a peptide or protein of interest fused in frame to a nucleic acid encoding the autophagosomal LC3 protein, or a functional fragment thereof, wherein said peptide or protein of interest is poorly or not presented efficiently on a major histocompatibility complex (MHC) class II molecule.
A method for stimulating or enhancing presentation of a peptide or protein of interest in the context of a major histocompatibility (MHC) class II molecule, the method comprising contacting a cell capable of expressing a major histocompatibility complex (MHC) class II molecule with a nucleic acid encoding a peptide or protein of interest fused in frame to a nucleic acid encoding an autophagosomal targeting protein, or a functional fragment thereof, whereby said autophagosomal targeting protein or a functional fragment thereof targets said peptide or protein of interest to an autophagosome, and said peptide, or a fragment of said protein of interest is displayed on the surface of said cell in the context of a major histocompatibility complex (MHC) class II molecule.
A method for stimulating or enhancing an immune response in a subject, the method comprising contacting a cell capable of expressing a major histocompatibility complex (MHC) class II molecule in said subject with a nucleic acid encoding a peptide or protein of interest fused in frame to a nucleic acid encoding an autophagosomal targeting protein, or a functional fragment thereof, whereby said autophagosomal targeting protein or functional fragment thereof targets said peptide or protein of interest to an autophagosome, and said peptide, or a fragment of said protein of interest is displayed on the surface of said cell in the context of a major histocompatibility complex (MHC) class II molecule, thereby stimulating or enhancing an immune response thereto.
A composition comprising a cell capable of expressing the major histocompatibility complex (MHC) class II protein, and a nucleic acid encoding a peptide or protein of interest fused in frame to a nucleic acid encoding the autophagosomal LC3 protein, or functional fragment thereof, or a vector comprising the same.
A method for downmodulating, suppressing or tolerizing an immune response in a subject to a peptide or protein of interest, the method comprising contacting immature dendritic cells with a nucleic acid encoding a peptide or protein of interest fused in frame to a nucleic acid encoding an autophagosomal targeting protein, or a functional fragment thereof, whereby said autophagosomal targeting protein or functional fragment thereof targets said peptide or protein of interest to an autophagosome, and said peptide, or a fragment of said protein of interest is displayed on the surface of said immature dendritic cell in the context of a major histocompatibility complex (MHC) class II molecule.
Dependencies are inferred from the claim text.